D Stolz

Summary

Affiliation: University Hospital
Country: Switzerland

Publications

  1. pmc Acute effects of aerosolized iloprost in COPD related pulmonary hypertension - a randomized controlled crossover trial
    Lucas Boeck
    Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, Switzerland
    PLoS ONE 7:e52248. 2012
  2. pmc Aspergillus-PCR in bronchoalveolar lavage for detection of invasive pulmonary aspergillosis in immunocompromised patients
    Michael Buess
    Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, Switzerland
    BMC Infect Dis 12:237. 2012
  3. pmc Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]
    Mirjam Christ-Crain
    Department of Internal Medicine, University Hospital Basel, Switzerland
    Crit Care 10:R96. 2006
  4. pmc Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia
    Beat Muller
    Departments of Internal Medicine, University Hospital, Petersgraben 4, CH 4031, Basel, Switzerland
    BMC Infect Dis 7:10. 2007
  5. ncbi BAL neutrophils, serum procalcitonin, and C-reactive protein to predict bacterial infection in the immunocompromised host
    Daiana Stolz
    University of Massachusetts Medical School, 55 Lake Ave North, Worcester, MA 01655, USA
    Chest 132:504-14. 2007
  6. ncbi Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD
    Daiana Stolz
    Clinic of Pneumology and Pulmonary Cell Research, University Hospital Basel, Petersgraben 4, CH 4031 Basel, Switzerland
    Chest 131:1058-67. 2007
  7. ncbi A randomised, controlled trial of bosentan in severe COPD
    D Stolz
    Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Petersgraben 4, CH 4031 Basel, Switzerland
    Eur Respir J 32:619-28. 2008
  8. ncbi Airway reactivity to inhaled mannitol in cigarette smokers: a longitudinal study
    Daiana Stolz
    Pulmonary Medicine and Respiratory Cell Research and Hospital Pharmacy, University Hospital Basel, Switzerland
    Respir Med 101:1470-6. 2007
  9. ncbi Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy
    Daiana Stolz
    Clinics of Respiratory Medicine and Pulmonary Cell Research, University Hospital Basel, Basel, Switzerland
    Chest 131:9-19. 2007
  10. ncbi Enhanced didactic methods of smoking cessation training for medical students--a randomized study
    Daiana Stolz
    Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Petersgraben 4, CH 4031 Basel, Switzerland
    Nicotine Tob Res 14:224-8. 2012

Collaborators

Detail Information

Publications39

  1. pmc Acute effects of aerosolized iloprost in COPD related pulmonary hypertension - a randomized controlled crossover trial
    Lucas Boeck
    Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, Switzerland
    PLoS ONE 7:e52248. 2012
    ..Inhaled iloprost potentially improves hemodynamics and gas exchange in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary hypertension (PH)...
  2. pmc Aspergillus-PCR in bronchoalveolar lavage for detection of invasive pulmonary aspergillosis in immunocompromised patients
    Michael Buess
    Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, Switzerland
    BMC Infect Dis 12:237. 2012
    ..We evaluated the diagnostic accuracy of conventional nested PCR in the bronchoalveolar fluid to diagnose IFD in severely immunocompromised patients...
  3. pmc Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]
    Mirjam Christ-Crain
    Department of Internal Medicine, University Hospital Basel, Switzerland
    Crit Care 10:R96. 2006
    ..A major cause of sepsis is community-acquired pneumonia (CAP). The aim of this study was to investigate the value of proADM levels for severity assessment and outcome prediction in CAP...
  4. pmc Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia
    Beat Muller
    Departments of Internal Medicine, University Hospital, Petersgraben 4, CH 4031, Basel, Switzerland
    BMC Infect Dis 7:10. 2007
    ..This study aims to evaluate the diagnostic and prognostic accuracy of clinical signs and symptoms and laboratory biomarkers for CAP...
  5. ncbi BAL neutrophils, serum procalcitonin, and C-reactive protein to predict bacterial infection in the immunocompromised host
    Daiana Stolz
    University of Massachusetts Medical School, 55 Lake Ave North, Worcester, MA 01655, USA
    Chest 132:504-14. 2007
    ....
  6. ncbi Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD
    Daiana Stolz
    Clinic of Pneumology and Pulmonary Cell Research, University Hospital Basel, Petersgraben 4, CH 4031 Basel, Switzerland
    Chest 131:1058-67. 2007
    ....
  7. ncbi A randomised, controlled trial of bosentan in severe COPD
    D Stolz
    Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Petersgraben 4, CH 4031 Basel, Switzerland
    Eur Respir J 32:619-28. 2008
    ....
  8. ncbi Airway reactivity to inhaled mannitol in cigarette smokers: a longitudinal study
    Daiana Stolz
    Pulmonary Medicine and Respiratory Cell Research and Hospital Pharmacy, University Hospital Basel, Switzerland
    Respir Med 101:1470-6. 2007
    ..AHR to mannitol is quite common in smokers compared to non-smokers and decreases significantly after smoking cessation. Thus, the mannitol test may be sensitive to non-asthmatic inflammation of the airways...
  9. ncbi Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy
    Daiana Stolz
    Clinics of Respiratory Medicine and Pulmonary Cell Research, University Hospital Basel, Basel, Switzerland
    Chest 131:9-19. 2007
    ..We evaluated the efficacy and safety of procalcitonin guidance compared to standard therapy with antibiotic prescriptions in patients experiencing exacerbations of COPD...
  10. ncbi Enhanced didactic methods of smoking cessation training for medical students--a randomized study
    Daiana Stolz
    Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Petersgraben 4, CH 4031 Basel, Switzerland
    Nicotine Tob Res 14:224-8. 2012
    ..It is essential that medical students are adequately trained in smoking cessation. A web-based tobacco abstinence training program might supplement or replace traditional didactic methods...
  11. ncbi Diagnostic value of signs, symptoms and laboratory values in lower respiratory tract infection
    Daiana Stolz
    Division of Pulmonary Medicine and Cell Research, University of Basel, Basel, Switzerland
    Swiss Med Wkly 136:434-40. 2006
    ..Using the outcome and microbiology findings as gold standard, we determined sensitivity, specificity, positive and negative predictive values of common used signs and symptoms of bacterial LRTI requiring antibiotic therapy...
  12. ncbi Propofol versus combined sedation in flexible bronchoscopy: a randomised non-inferiority trial
    D Stolz
    Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland
    Eur Respir J 34:1024-30. 2009
    ..460). Propofol is as effective and safe as combined sedation in patients undergoing flexible bronchoscopy, thus representing an appealing option if timely discharge is a priority...
  13. ncbi Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study
    D Stolz
    Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital, Petersgraben 4, CH 4031 Basel, Switzerland
    Eur Respir J 34:1364-75. 2009
    ..Serum procalcitonin reduces antibiotic therapy exposure in patients with ventilator associated pneumonia...
  14. ncbi Use of B-type natriuretic peptide in the risk stratification of community-acquired pneumonia
    M Christ-Crain
    Department of Internal Medicine, University Hospital Basel, Basel, Switzerland
    J Intern Med 264:166-76. 2008
    ..Community-acquired pneumonia (CAP) is the leading infectious cause of death in developed countries. Risk stratification has previously been difficult...
  15. doi Midregional pro-atrial natriuretic peptide and procalcitonin improve survival prediction in VAP
    L Boeck
    Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital, Petersgraben 4, CH 4031 Basel, Switzerland
    Eur Respir J 37:595-603. 2011
    ..895 and 0.880). We conclude that the combination of two biomarkers, MR-proANP and PCT, improve survival prediction of clinical severity scores in VAP...
  16. ncbi Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections
    B Muller
    University Hospital Basel, Switzerland
    Eur J Clin Invest 37:145-52. 2007
    ..Lower respiratory tract infections (LRTI) are a precursor of sepsis. Thus, we investigated circulating levels and the prognostic use of copeptin for the severity and outcome in patients with LRTI...
  17. pmc Predicting mortality with pneumonia severity scores: importance of model recalibration to local settings
    P Schuetz
    University Hospital Basel, Department of Internal Medicine, Basel, Switzerland
    Epidemiol Infect 136:1628-37. 2008
    ....
  18. ncbi Circulating levels of pro-atrial natriuretic peptide in lower respiratory tract infections
    B Muller
    Department of Internal Medicine, University Hospital Basel, Basel, Switzerland
    J Intern Med 260:568-76. 2006
    ..To analyse the mid region of plasma N-terminal pro-atrial natriuretic peptide (MR-proANP) levels in patients with lower respiratory tract infections to evaluate its prognostic use for the severity of disease and outcome...
  19. ncbi Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of COPD
    Daiana Stolz
    Clinic for Pneumology and Respiratory Cell Research, University Hospital Basel, Switzerland
    Chest 133:1088-94. 2008
    ..In patients with COPD, prognosis might be determined at least in part by the extent of cardiac stress induced by hypoxia and pulmonary arterial hypertension...
  20. ncbi Respiratory symptoms, atopy and bronchial hyperreactivity in professional firefighters
    D Miedinger
    Department of Internal Medicine, University Hospital, 4031 Basel, Switzerland
    Eur Respir J 30:538-44. 2007
    ..It remains unclear whether these findings were present at recruitment or developed after joining the workforce...
  21. pmc Cough suppression during flexible bronchoscopy using combined sedation with midazolam and hydrocodone: a randomised, double blind, placebo controlled trial
    D Stolz
    Division of Respiratory Medicine and Pulmonary Cell Research, University Hospital Basel, Basel, Switzerland
    Thorax 59:773-6. 2004
    ..A randomised, placebo controlled, double blind study was undertaken to determine whether hydrocodone in combination with midazolan improves cough suppression during FB without increasing the risk of desaturation...
  22. doi Propofol versus propofol plus hydrocodone for flexible bronchoscopy: a randomised study
    L Schlatter
    Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, Switzerland
    Eur Respir J 38:529-37. 2011
    ..The duration of the procedure, time to discharge and complication rate were similar in both groups. The combination of propofol and hydrocodone is safe and superior to propofol alone for cough suppression in flexible bronchoscopy...
  23. ncbi A randomized, placebo-controlled trial of bronchodilators for bronchoscopy in patients with COPD
    Daiana Stolz
    Department of Pulmonary, Allergy and Critical Care Medicine, University of Massachusetts Memorial Hospital, 55 Lake Ave N, Worcester, MA 01655, USA
    Chest 131:765-72. 2007
    ..We therefore performed a randomized, double-blind, placebo-controlled trial to determine whether use of a short-acting bronchodilator provides a protective effect in patients with COPD undergoing bronchoscopy...
  24. doi Bronchoscopic lung volume reduction--current opinion
    Michael Tamm
    Clinic of Pneumology and Respiratory Cell Research, University Hospital Basel, Switzerland
    Swiss Med Wkly 140:w13140. 2010
    ..This article discusses newest developments and results in bronchoscopic lung volume reduction...
  25. doi Feasibility and safety of propofol sedation in flexible bronchoscopy
    Peter Grendelmeier
    Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, Switzerland
    Swiss Med Wkly 141:w13248. 2011
    ..There are only limited data evaluating propofol for flexible bronchoscopy. We analysed the feasibility and safety of propofol for bronchoscopy in a high output tertiary care centre...
  26. ncbi Diagnostic tests for asthma in firefighters
    David Miedinger
    Clinic for Pneumology, University Hospital, Basel, Switzerland
    Chest 131:1760-7. 2007
    ..Subjects with asthma do not meet medical requirements for professions such as firefighting...
  27. ncbi Plasma pro-adrenomedullin but not plasma pro-endothelin predicts survival in exacerbations of COPD
    Daiana Stolz
    Clinic of Pneumology, University Hospital Basel, Petersgraben 4, CH 4031 Basel, Switzerland
    Chest 134:263-72. 2008
    ..We investigated whether plasma pro-endothelin-1 (proET-1) and/or pro-adrenomedullin (proADM) on admission to the hospital for acute exacerbation predict survival in patients with COPD...
  28. pmc Endothelin-1 precursor peptides correlate with severity of disease and outcome in patients with community acquired pneumonia
    Philipp Schuetz
    Department of Internal Medicine, University Hospital Basel, Switzerland
    BMC Infect Dis 8:22. 2008
    ..The objective of this study was to assess the diagnostic and prognostic value of proET-1 in a prospective cohort of mainly septic patients with community-acquired pneumonia...
  29. ncbi Reliability and validity of a German asthma quality of life questionnaire
    David Miedinger
    Department of Internal Medicine, University Hospital, Basel, Switzerland
    Swiss Med Wkly 136:89-95. 2006
    ..The German translation of the AQLQ-Sydney had a good internal consistency and test-retest-reliability in stable asthmatic patients. It shows responsiveness to treatment. Some correlations with objective markers were detected...
  30. doi Discriminate use of antibiotics for exacerbation of COPD
    Daiana Stolz
    Clinic of Respiratory Medicine and Pulmonary Cell Research, University Hospital Basel, Petersgraben 4, Basel CH 4031, Switzerland
    Curr Opin Pulm Med 15:126-32. 2009
    ....
  31. ncbi Prediction of treatment-response to inhaled corticosteroids by mannitol-challenge test in COPD. A proof of concept
    Jorg D Leuppi
    Pneumology, Department of Internal Medicine, University Hospital, Petersgraben 4, Basel CH 4031, Switzerland
    Pulm Pharmacol Ther 18:83-8. 2005
    ..There are no predictors known that can identify COPD patients who will respond to treatment with ICS...
  32. ncbi Sedative drug requirements during flexible bronchoscopy
    Prashant N Chhajed
    Pulmonary Medicine, University Hospital Basel, Petersgraben 4, CH 1031 Basel, Switzerland
    Respiration 72:617-21. 2005
    ..There is a paucity of data comparing doses of sedative medication during bronchoscopy in immunosuppressed and non-immunosuppressed patients...
  33. ncbi Nebulized lidocaine for flexible bronchoscopy: a randomized, double-blind, placebo-controlled trial
    Daiana Stolz
    Division of Respiratory Medicine and Pulmonary Cell Research, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland
    Chest 128:1756-60. 2005
    ..We performed a prospective, randomized, double-blind, placebo-controlled trial to evaluate whether nebulized lidocaine provides additional benefit and reduces the total anesthetic dose required during bronchoscopy...
  34. ncbi Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial
    Mirjam Christ-Crain
    Department of Internal Medicine, University Hospital, Basel, Switzerland
    Am J Respir Crit Care Med 174:84-93. 2006
    ..In patients with community-acquired pneumonia, guidelines recommend antibiotic treatment for 7 to 21 d. Procalcitonin is elevated in bacterial infections, and its dynamics have prognostic implications...
  35. ncbi Perimenstrual increase in bronchial hyperreactivity in premenopausal women: results from the population-based SAPALDIA 2 cohort
    Julia Dratva
    Institute of Social and Preventive Medicine at the Swiss Tropical Institute, Basel, Switzerland
    J Allergy Clin Immunol 125:823-9. 2010
    ..Studies on perimenstrual asthma are inconsistent, and different methodologies limit comparisons...
  36. doi Prognostic impact of plasma lipids in patients with lower respiratory tract infections - an observational study
    Maja Gruber
    Clinic of Endocrinology, Diabetology and Clinical Nutrition, University Hospital, Basel, Switzerland
    Swiss Med Wkly 139:166-72. 2009
    ..Whether lipids have prognostic implications or could help to differentiate community-acquired pneumonia from other lower respiratory tract infections remains unknown...
  37. doi Pancreatic stone protein: a marker of organ failure and outcome in ventilator-associated pneumonia
    Lucas Boeck
    Clinic of Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, Switzerland
    Chest 140:925-32. 2011
    ..The prognostic value of PSP/reg among critically ill patients is unknown. The aim of this pilot study was to evaluate PSP/reg in VAP...
  38. ncbi Circulating levels of soluble triggering receptor expressed on myeloid cells (sTREM)-1 in community-acquired pneumonia
    Beat Muller
    Crit Care Med 35:990-1. 2007
  39. ncbi Free and total cortisol levels as predictors of severity and outcome in community-acquired pneumonia
    Mirjam Christ-Crain
    Department of Endocrinology, William Harvey Research Institute, Barts and The London, Queen Mary s School of Medicine and Dentistry, London, United Kingdom
    Am J Respir Crit Care Med 176:913-20. 2007
    ..The predictive value of cortisol in pneumonia is unknown. Routinely available assays measure serum total cortisol (TC) and not free cortisol (FC). Whether FC concentrations better reflect outcome is uncertain...